Sage Rhino Capital »

Takeda Pharmaceutical shares owned by Sage Rhino Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Sage Rhino Capital from 13F filings

Historical chart of Sage Rhino Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Sage Rhino Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Sage Rhino Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $147k 10k 14.22
2024-03-31 $164k 12k 13.89
2023-09-30 $182k 12k 15.47
2023-06-30 $172k 11k 15.71
2023-03-31 $177k 11k 16.48

More positions owned by Sage Rhino Capital

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Gold Tr Ishares New (IAU)
Vanguard Index Fds Small Cp Etf (VB)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Spdr Ser Tr S&p Divid Etf (SDY)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Sage Rhino Capital

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical